New Method Of Treatment Glaucoma

New Method Of Treatment Glaucoma.
Contact lenses that transport glaucoma medication over hanker periods are getting closer to reality, say researchers working with laboratory animals. In their study, the lenses delivered the glaucoma soporific latanoprost (brand name Xalatan) continuously to animals for a month. It's hoped that some heyday such lenses will replace eye drops now worn to treat the eye disease, the researchers said Dec 2013.

And "In general, percipience drops are an inefficient method of drug delivery that has notoriously poor patient adherence," scan lead author Dr Joseph Ciolino, a cornea specialist at the Massachusetts Eye and Ear Infirmary, said in an surgery news release. "This contact lens conceive of can potentially be used as a treatment for glaucoma and as a platform for other eye drug delivery applications". Glaucoma is the matchless cause of irreversible blindness worldwide.

The lenses, which appeared safe in cell culture and bestial studies, are the first to be shown to release drugs for this long in animals, according to the researchers. The study appears online and in the January woodcut issue of the journal Biomaterials. The lens the research side developed "is capable of delivering large amounts of drug at substantially constant rates over weeks to months," Daniel Kohane, chief honcho of the Laboratory for Biomaterials and Drug Delivery at Boston Children's Hospital, said in the dirt release top. Ciolino said a noninvasive method of uniform eye-drug delivery could save millions of people from blindness if it helps them comply with their medication regimen.